Sign in to fuzzto save your conversations, follow your research and come back anytime.
Molbio Diagnostics
| Metric (₹ crore) | Q1 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|
| Sales | 99.71 | 560.62 | 408.38 |
| Expenses | 115.81 | 401.9 | 307.79 |
| EBITDA | -16.1 | 158.72 | 100.59 |
| Depreciation | 12.32 | 19.6 | 17.08 |
| EBIT | -28.42 | 139.12 | 83.51 |
| Interest | 3.61 | 12.08 | 10.7 |
| Profit Before Tax | -32.03 | 127.04 | 72.81 |
| Net Profit | -23.94 | 95.83 | 52.74 |
| EPS | -2.1 | 8.05 | 5.21 |
| Metric (₹ crore) | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 360.12 | 100.78 | 64.13 | 9.57 | 287.1 | 50.39 |
| Investing Cash Flow | -144.83 | -88.15 | -39.73 | -45.01 | -122.65 | -53.91 |
| Financing Cash Flow | -203.86 | -21.94 | 18.24 | -31.55 | -26.15 | 276.07 |
| Net Cash Flow | 11.43 | -9.31 | 42.64 | -66.99 | 138.3 | 272.55 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | -124.57 | 335.15 | 710.99 | 737.34 | 828.84 | 967.28 | 1,308.78 |
| Total Liabilities | 439.9 | 509.98 | 228.68 | 296.87 | 392.22 | 494.27 | 839.65 |
| Total Assets | 315.33 | 845.13 | 939.67 | 1,034.21 | 1,221.06 | 1,461.56 | 2,148.42 |